Expanding the genetic code of the human hematopoietic system

Area of Science:

• Biochemistry
• Molecular Biology
• Genetics

Background:

• Noncanonical amino acids (ncAAs) have been genetically incorporated into proteins in various organisms, including mammals.
• However, achieving this in human-derived tissues has remained a significant challenge.

Purpose of the Study:

• To develop a method for the long-term genetic encoding of ncAAs in human hematopoietic stem cells.
• To establish a functional, genetically engineered hematopoietic system in a mouse model.

Main Methods:

• Utilized a self-replicating Epstein-Barr virus-based episomal vector.
• Engineered human hematopoietic stem cells for ncAAs incorporation.
• Reconstituted the hematopoietic system in mice using these engineered cells.

Main Results:

• Successfully demonstrated long-term encoding of ncAAs in human hematopoietic stem cells.
• Established a reconstituted hematopoietic system in mice with the engineered cells.
• Paved the way for introducing novel amino acids into human cells.

Conclusions:

• The developed vector system enables stable genetic incorporation of ncAAs in human hematopoietic stem cells.
• This represents a significant advancement in synthetic biology and regenerative medicine.
• Opens new avenues for protein engineering and therapeutic applications in humans.